Increased vasoactive mediator releasability: a possible pathogenic factor of atopic dermatitis.
D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage*; D002794:Choline / Q000031:analogs & derivatives / Q000494:pharmacology; D003876:Dermatitis, Atopic / Q000097:blood / Q000276:immunology*; D004305:Dose-Response Relationship, Drug; D004306:Dose-Response Relationship, Immunologic; D006632:Histamine / Q000097:blood; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology*; D066298:In Vitro Techniques; D007962:Leukocytes / Q000378:metabolism
D000888:Antibodies, Anti-Idiotypic; C017506:methylcholine; D007073:Immunoglobulin E; D006632:Histamine; D002794:Choline